92%
Finnrick rating
#3 of 186 Tirzepatide vendors
16 of 16 classifiable tests passed
natural 100% · customers 4.9★ (12)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Andy Peps Studio tirzepatide shows a low-concern purity-focus profile, with identity passes and purity at 99.7–99.95% across tests. Recent fills tightened after earlier +19% and -11% swings; batch-source documentation is uneven.

methodology →
vendor intelligence report
Vendor Intelligence Report: Andy Peps Studio

APS publicly disavowed an APS-branded storefront that kept operating, changed contact presentation, and showed a later WHOIS update. The report also maps linked retail infrastructure, COA provenance gaps, and forum-reputation signals.

26 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatideselected
$0.37
92%
16
2
Retatrutide
$0.80
86%
12
3
BPC-157
$0.60
59%
6
4
Tesamorelin
$1.70
53%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%30 Sept 2025: 78%30 Sept 2025: 79%30 Sept 2025: 80%3 Oct 2025: 83%3 Oct 2025: 84%1 Jan 2026: 86%22 Jan 2026: 87%26 Feb 2026: 87%13 Mar 2026: 88%13 Mar 2026: 89%23 Apr 2026: 89%28 Apr 2026: 90%19 May 2026: 91%28 May 2026: 91%4 Aug 2026: 92%9 Aug 2026: current 92%78%87%92%Sep 25Aug 26
Showing Tirzepatide tests only
Andy Peps Studio Tirzepatide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
4 Aug 2026Pass
Tested
lab nameView COA
28 May 2026Pass
Tested
lab nameView COA
19 May 2026Pass
Tested
lab nameView COA
28 Apr 2026Pass
Tested
lab nameView COA
23 Apr 2026Pass
Tested
lab nameView COA
13 Mar 2026Pass
Tested
lab nameView COA
13 Mar 2026Pass
Tested
lab nameView COA
26 Feb 2026Pass
Tested
lab nameView COA
22 Jan 2026Pass
Tested
lab nameView COA
1 Jan 2026Pass
Tested
lab nameView COA
1-10 of 16

About Andy Peps Studio test results from Finnrick

Andy Peps Studio is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 39 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Andy Peps Studio peptides in this dataset are Tirzepatide (16 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 39 recent tests.

Corrections
No corrections.